摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one | 679410-74-3

中文名称
——
中文别名
——
英文名称
1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one
英文别名
——
1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one化学式
CAS
679410-74-3
化学式
C19H22O4
mdl
——
分子量
314.381
InChiKey
SRTRIAUTERYVEJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    23
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one 在 cerium(III) chloride 、 copper diacetate 、 四丁基氟化铵三乙胺氯甲酸甲酯 、 sodium iodide 作用下, 以 四氢呋喃二氯甲烷乙腈 为溶剂, 反应 7.0h, 生成 4-{5-methoxy-2-[2-(4-methoxyphenyl)-2-methylpropyl]phenoxy}phenol
    参考文献:
    名称:
    A New Series of Estrogen Receptor Modulators: Effect of Alkyl Substituents on Receptor-Binding Affinity
    摘要:
    新型选择性雌激素受体调节剂(SERMs)被合成并评估其与生殖细胞的结合亲和力和生物学效应。提议的先导结构(B)被衍生化以提供化合物30和44,这些化合物显示出良好的雌激素受体结合亲和力(Ki值:分别为6.3和10 nM),同时对乳腺癌和子宫癌细胞的影响较小。核心结构中引入烷基基团显著增强了测试化合物的受体结合亲和力。文中描述了这些化合物的合成及其结构–活性关系。
    DOI:
    10.1248/cpb.52.79
  • 作为产物:
    描述:
    1-(2,4-二甲氧基苯基)-2-(4-甲氧基苯基)乙酮碘甲烷18-冠醚-6potassium tert-butylate 作用下, 以 四氢呋喃 为溶剂, 反应 0.8h, 以84%的产率得到1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one
    参考文献:
    名称:
    A New Series of Estrogen Receptor Modulators: Effect of Alkyl Substituents on Receptor-Binding Affinity
    摘要:
    新型选择性雌激素受体调节剂(SERMs)被合成并评估其与生殖细胞的结合亲和力和生物学效应。提议的先导结构(B)被衍生化以提供化合物30和44,这些化合物显示出良好的雌激素受体结合亲和力(Ki值:分别为6.3和10 nM),同时对乳腺癌和子宫癌细胞的影响较小。核心结构中引入烷基基团显著增强了测试化合物的受体结合亲和力。文中描述了这些化合物的合成及其结构–活性关系。
    DOI:
    10.1248/cpb.52.79
点击查看最新优质反应信息

文献信息

  • Selective Estrogen Receptor Modulator
    申请人:Hamaoka Shinichi
    公开号:US20120004315A1
    公开(公告)日:2012-01-05
    The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof.
    本发明提供一种由以下式(I)表示的化合物; [其中T表示单键,可能具有取代基的C1-C4烷基和类似物;式(I-1)表示单键或双键;A表示单键,可能具有取代基的双价5-至14-成员杂环基和类似物;Y表示单键和类似物;Z表示亚甲基基团和类似物;环G表示苯基团和类似物,可能与5-至6-成员环缩合并可能具有杂原子;Ra和Rb相同或不同,表示氢原子和类似物;W表示单键和类似物;R'表示1到4个独立的氢原子和类似物;R''表示1到4个独立的氢原子和类似物]或其盐或水合物。
  • Selective estrogen receptor modulator
    申请人:Hamaoka Shinichi
    公开号:US20060116364A1
    公开(公告)日:2006-06-01
    The present invention provides a compound represented by the following formula [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof
    本发明提供了一种化合物,其表示为以下式子[其中T表示单键,C1-C4的烷基,可能带有取代基等;式(I-1)表示单键或双键;A表示单键,二价的5-至14-成员杂环基团,可能带有取代基等;Y表示单键等;Z表示亚甲基等;环G表示苯基团等,可与5-至6-成员环缩合并且可能具有杂原子;Ra和Rb相同或不同,表示氢原子等;W表示单键等;R'表示1至4个独立的氢原子等;R"表示1至4个独立的氢原子等]或其盐,或其水合物。
  • SELECTIVE ESTROGEN RECEPTOR MODULATOR
    申请人:Hamaoka Shinichi
    公开号:US20090325930A1
    公开(公告)日:2009-12-31
    The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; (I-1) formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof.
    本发明提供了一种由以下式(I)表示的化合物;[其中,T表示单键,C1-C4烷基,可以有取代基等;(I-1)式(I-1)表示单键或双键;A表示单键,双价的5-至14-成员杂环基,可以有取代基等;Y表示单键等;Z表示亚甲基等;环G表示苯基等,可以与5-至6-成员环缩合,可以有杂原子;Ra和Rb相同或不同,表示氢原子等;W表示单键等;R′表示1至4个独立的氢原子等;R″表示1至4个独立的氢原子等]或其盐,或其水合物。
  • SELECTIVE ESTROGEN RECEPTOR MODULATORS
    申请人:Eisai Co., Ltd.
    公开号:EP1577288A1
    公开(公告)日:2005-09-21
    The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; Ra and Rb are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R' represents 1 to 4 independent hydrogen atoms and the like; and R" represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof.
    本发明提供了由下式(I)代表的化合物; [其中 T 代表单键、可能具有取代基的 C1-C4 亚烷基等; 式(I-1)代表单键或双键;A 代表单键、可具有取代基等的二价 5 至 14 元杂环基团;Y 代表单键等;Z 代表亚甲基等;环 G 代表可与 5 至 6 元环缩合且可具有杂原子的亚苯基等;Ra和Rb彼此相同或不同,代表氢原子等;W代表单键等;R'代表1至4个独立氢原子等;R "代表1至4个独立氢原子等]或其盐或其水合物。
  • Selective estrogen receptor modulators
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP1577288B1
    公开(公告)日:2014-07-23
查看更多

同类化合物

安哥拉紫檀素 2-羟基-3-苯基苯丙酮 1-(2,4-二羟基苯基-3,5-d2)-2-(4-羟基苯基-3,5-d2)丙烷-1-酮-2-d1 1-(2,4-二羟基苯基)-2-(4-羟基苯基)丙-1-酮 1-(1-羟基萘-2-基)-2-甲基-2-苯基丙烷-1-酮 1-(2-hydroxy-5-methylphenyl)-3-(naphthalen-1-yl)-2-phenylpropan-1-one 2,4,5,4'-tetramethoxy-α-methyldesoxybenzoin 1-[2-(1-hydroxynaphthyl)]-2-phenyl-1-propanone 1-(4-(cyc lohexyloxy)-2-methoxyphenyl)-2-(3,4-dimethoxyphenyl)propan-1-one 2-(3,4-dimethoxyphenyl)-1-(4-hydroxy-2-methoxyphenyl)propan-1-one 1-(2-Hydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl)propan-1-one 1-(2-methoxyphenyl)-2-phenylpropan-1-one 2-(2-fluorophenyl)-1-(2-methoxy-4-(piperidin-1-yl)phenyl)propan-1-one (-)-angolensin (-)-angolensin-4-methyl ether 1-(2-methoxyphenyl)-2-phenyl-2-(trimethylsilyloxy)propan-1-one 1-(2,5-dimethoxy-4-methylphenyl)-2-phenylpropan-1-one (+/-)-1-<2,5-Dimethyl-phenyl>-2-phenyl-propan-1-on 1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)-[1,2,3-(13)C3]propan-1-one 1,2-bis(2-hydroxybenzoyl)-1-propanone 2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)-2-methylpropan-1-one (+/-)-2-<2,4-Bis(methoxymethoxy)phenyl>-1-<2-hydroxy-4-(methoxymethoxy)phenyl>propan-1-on 1-(2-hydroxyphenyl)-2-(4-methoxyphenyl)propan-1-one 1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one 1-(2-hydroxy-4-methoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one 1-(2-hydroxy-4-methoxyphenyl)-2-phenylpropan-1-one 1-(2-hydroxyphenyl)-2-(2-hydroxy-4-methoxyphenyl)-1-propanone 2-hydroxy-3,4-dimethoxy-α-C-methoxydesoxybenzoin (R)-2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propan-1-one 2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propan-1-one 1-(2,5-dihydroxy-4-methoxyphenyl)-2-(4'-hydroxyphenyl)-1-propanone 1-(5-Bromo-2-hydroxyphenyl)-2-(2-nitrophenyl)propan-1-one 1-(2,5-dihydroxy-4-methoxyphenyl)-2-phenyl-1-propanone 1-(2,4-Dihydroxyphenyl)-2-phenylpropan-1-one 1-(2,3,4-trihydroxyphenyl)-2-phenyl-1-propanone (S)-2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propan-1-one Ethyl 4-[1-[4-(dimethylamino)-2-hydroxyphenyl]-1-oxopropan-2-yl]benzoate 2-[[2-(2-Methyl-2-phenylpropanoyl)phenoxy]methoxy]propyl benzoate (2S)-1-(2,4-dihydroxyphenyl)-2-(4-methoxyphenyl)propan-1-one 1-[2,4-Bis(trimethylsiloxy)phenyl]-2-[(4-trimethylsiloxy)phenyl]propan-1-one 1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)propan-1-one (+/-)-Di-O-acetyl-angolensin 4'-hydroxy-2,4-dimethoxy-α-methyldeoxybenzoin 1-(2,3,4-dihydroxyphenyl)-2-(4'-hydroxyphenyl)-1-propanone 1-(2,4-Dihydroxyphenyl)-2-(3-hydroxy-4-methoxyphenyl)propan-1-one 2-(4-Methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one 1-(2,4-Dihydroxyphenyl)-2-(3,5-dimethoxyphenyl)propan-1-one 1-[4-[(1,6-dimethyl-4-propan-2-yl-3,4,4a,7,8,8a-hexahydro-2H-naphthalen-1-yl)oxy]-2-hydroxyphenyl]-2-(4-methoxyphenyl)propan-1-one 1-(2,4-Dihydroxy-5-methoxyphenyl)-2-(4-hydroxyphenyl)propan-1-one (+/-)-4-O-methylangolensin